Koninklijke Philips - 41 Year Stock Price History | PHG
Historical daily share price chart and data for Koninklijke Philips since 1984 adjusted for splits and dividends. The latest closing stock price for Koninklijke Philips as of May 19, 2025 is 23.87.
- The all-time high Koninklijke Philips stock closing price was 51.22 on April 23, 2021.
- The Koninklijke Philips 52-week high stock price is 32.91, which is 37.9% above the current share price.
- The Koninklijke Philips 52-week low stock price is 21.48, which is 10% below the current share price.
- The average Koninklijke Philips stock price for the last 52 weeks is 27.09.
| Koninklijke Philips Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 24.7896 | 24.0961 | 27.5976 | 20.9032 | 23.8700 | -2.27% |
| 2024 | 24.5683 | 21.6584 | 31.5815 | 18.4964 | 24.4241 | 12.24% |
| 2023 | 18.0597 | 13.9645 | 21.8263 | 13.9645 | 21.7610 | 62.59% |
| 2022 | 19.9852 | 32.4151 | 33.1329 | 10.4912 | 13.3841 | -57.50% |
| 2021 | 42.2259 | 46.6930 | 51.2197 | 28.9625 | 31.4921 | -30.65% |
| 2020 | 38.9195 | 39.6578 | 46.0810 | 25.5458 | 45.4104 | 16.05% |
| 2019 | 34.0453 | 27.1330 | 39.3531 | 25.8275 | 39.1286 | 42.57% |
| 2018 | 31.5529 | 28.7739 | 36.2477 | 26.4529 | 27.4457 | -4.69% |
| 2017 | 27.0723 | 22.3786 | 32.0725 | 21.4662 | 28.7967 | 27.00% |
| 2016 | 20.0464 | 17.8636 | 22.6753 | 16.9136 | 22.6753 | 24.74% |
| 2015 | 19.1698 | 20.1063 | 20.8777 | 16.5636 | 18.1778 | -9.00% |
| 2014 | 21.6328 | 24.2852 | 25.4182 | 18.1570 | 19.9754 | -18.46% |
| 2013 | 20.3001 | 17.3330 | 24.4972 | 16.9507 | 24.4972 | 44.85% |
| 2012 | 13.6001 | 12.9291 | 17.0845 | 10.8274 | 16.9124 | 34.06% |
| 2011 | 15.0223 | 18.2316 | 19.6622 | 10.1590 | 12.6159 | -29.34% |
| 2010 | 17.8537 | 17.3632 | 20.8776 | 15.6088 | 17.8536 | 7.68% |
| 2009 | 11.9376 | 10.9683 | 17.0028 | 7.3969 | 16.5804 | 57.71% |
| 2008 | 16.6921 | 21.7505 | 21.7505 | 7.8255 | 10.5133 | -52.13% |
| 2007 | 20.8312 | 18.9072 | 23.5639 | 17.7620 | 21.9611 | 16.34% |
| 2006 | 16.7068 | 15.9814 | 19.0579 | 13.8288 | 18.8771 | 22.94% |
| 2005 | 13.1679 | 12.7474 | 15.7839 | 11.5969 | 15.3544 | 19.86% |
| 2004 | 12.8254 | 14.1916 | 15.8260 | 10.6205 | 12.8103 | -7.31% |
| 2003 | 10.1112 | 8.7681 | 14.0680 | 6.6050 | 13.8210 | 68.77% |
| 2002 | 11.0227 | 13.7628 | 15.2295 | 6.0585 | 8.1891 | -38.58% |
| 2001 | 12.9877 | 15.9053 | 19.2671 | 7.6303 | 13.3323 | -18.63% |
| 2000 | 19.2506 | 15.8716 | 24.4468 | 14.1537 | 16.3855 | 7.83% |
| 1999 | 10.9082 | 8.3036 | 15.1962 | 8.0219 | 15.1962 | 89.26% |
| 1998 | 8.6548 | 7.1575 | 12.0551 | 5.4122 | 8.0293 | 13.34% |
| 1997 | 7.2663 | 4.5231 | 10.3777 | 4.5087 | 7.0843 | 54.18% |
| 1996 | 4.1427 | 4.1630 | 4.7777 | 3.3600 | 4.5949 | 14.60% |
| 1995 | 4.4350 | 3.3384 | 5.9232 | 3.3106 | 4.0094 | 22.65% |
| 1994 | 3.1950 | 2.3100 | 3.7557 | 2.3100 | 3.2689 | 46.66% |
| 1993 | 1.7859 | 1.2023 | 2.3235 | 1.2023 | 2.2289 | 91.87% |
| 1992 | 1.7594 | 1.8642 | 2.3370 | 1.0942 | 1.1617 | -38.57% |
| 1991 | 1.7531 | 1.2698 | 2.1208 | 1.2158 | 1.8912 | 48.94% |
| 1990 | 1.8150 | 2.5720 | 2.5720 | 1.1888 | 1.2698 | -51.62% |
| 1989 | 2.0220 | 1.7648 | 2.6376 | 1.7010 | 2.6245 | 51.97% |
| 1988 | 1.4991 | 1.4211 | 1.7651 | 1.2181 | 1.7270 | 24.67% |
| 1987 | 2.1091 | 1.8475 | 2.5468 | 1.3497 | 1.3853 | -24.07% |
| 1986 | 1.9789 | 1.9340 | 2.2700 | 1.7025 | 1.8245 | -3.55% |
| 1985 | 1.3102 | 1.1794 | 1.8917 | 1.1605 | 1.8917 | 60.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.587B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
| Boston Scientific (BSX) | United States | $156.881B | 39.27 |
| Stryker (SYK) | United States | $150.466B | 31.46 |
| EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
| Medtronic (MDT) | Ireland | $110.863B | 16.19 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.673B | 27.69 |
| ResMed (RMD) | United States | $36.905B | 27.72 |
| GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
| Agilent Technologies (A) | United States | $32.436B | 21.43 |
| Terumo (TRUMY) | Japan | $27.642B | 35.90 |
| Insulet (PODD) | United States | $22.854B | 89.71 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
| Baxter (BAX) | United States | $16.247B | 12.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Haemonetics (HAE) | United States | $3.532B | 15.39 |
| ICU Medical (ICUI) | United States | $3.480B | 25.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| QuidelOrtho (QDEL) | United States | $2.263B | 15.56 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.81 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.435B | 18.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
| BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
| InMode (INMD) | Israel | $1.020B | 9.34 |
| Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
| CeriBell (CBLL) | United States | $0.649B | 0.00 |
| Evolus (EOLS) | United States | $0.625B | 0.00 |
| Owens & Minor (OMI) | United States | $0.570B | 4.73 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.409B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Brainsway (BWAY) | Israel | $0.187B | 49.55 |
| Quanterix (QTRX) | United States | $0.186B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.58 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.080B | 10.32 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.86 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |